NCT06724016
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06724016
Title Dose Escalation and Expansion Study of HM16390 in Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hanmi Pharmaceutical Company Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute NOT_YET_RECRUITING Detroit Michigan 48201 United States Details
Seoul National University Bundang Hospital RECRUITING Seongnam-si Gyeonggi-do 13620 South Korea Details
Seoul National University Hospital RECRUITING Seoul 03080 South Korea Details
Severance Hospital RECRUITING Seoul 03722 South Korea Details
Asan Medical Center ACTIVE_NOT_RECRUITING Seoul 05505 South Korea Details
Samsung Medical Center RECRUITING Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field